News headlines DexCom (DXCM) is positioned as a strong long-term investment in the healthcare sector, benefiting from regulatory changes and recent upgrades by analysts. The company's continuous ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

FORMER Ireland star Conor Murray believes Ciaran Frawley’s upcoming move to Connacht is proof that the Irish rugby system is ...

DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...

Ireland will also play Wales at Affidea Stadium in Belfast before finishing campaign with Aviva Stadium date against Scotland ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Dexcom’s G6 (left) and G7 (right) side-by-side. [Image from Dexcom] A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose monitor ...

As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...